tRNA therapeutics burst onto startup scene - Nature
文章推薦指數: 80 %
Companies advance tRNA therapeutics to overcome mutant stoppages in protein synthesis shared by thousands of genetic diseases and cancers. Skiptomaincontent Thankyouforvisitingnature.com.YouareusingabrowserversionwithlimitedsupportforCSS.Toobtain thebestexperience,werecommendyouuseamoreuptodatebrowser(orturnoffcompatibilitymodein InternetExplorer).Inthemeantime,toensurecontinuedsupport,wearedisplayingthesitewithoutstyles andJavaScript. Advertisement nature naturebiotechnology news article CompaniesadvancetRNAtherapeuticstoovercomemutantstoppagesinproteinsynthesissharedbythousandsofgeneticdiseasesandcancers. ButAlltrnaishardlyaloneinitspursuitoftRNA-basedtherapeutics.ReCodeTherapeutics,ShapeTherapeuticsandTevardBiosciencesallcamebeforeit;andthefieldcontinuestoexpandwiththearrivalofhCBioscience,astartupthatemergedfromstealthmodeinlateFebruarywith$24millionandaplantofightcancerandrarediseaseswithtRNA. Thisisapreviewofsubscriptioncontent Accessoptions Accessthroughyourinstitution Changeinstitution Buyorsubscribe SubscribetoJournalGetfulljournalaccessfor1year92,52€only7,71€perissueSubscribeAllpricesareNETprices.VATwillbeaddedlaterinthecheckout.Taxcalculationwillbefinalisedduringcheckout.BuyarticleGettimelimitedorfullarticleaccessonReadCube.$32.00BuyAllpricesareNETprices. Additionalaccessoptions: Login Learnaboutinstitutionalsubscriptions AuthorinformationAuthorsandAffiliationsSomerville,MA,USAElieDolginAuthorsElieDolginViewauthorpublicationsYoucanalsosearchforthisauthorin PubMed GoogleScholarRightsandpermissionsReprintsandPermissionsAboutthisarticleCitethisarticleDolgin,E.tRNAtherapeuticsburstontostartupscene. NatBiotechnol40,283–286(2022).https://doi.org/10.1038/s41587-022-01252-yDownloadcitationPublished:24February2022IssueDate:March2022DOI:https://doi.org/10.1038/s41587-022-01252-ySharethisarticleAnyoneyousharethefollowinglinkwithwillbeabletoreadthiscontent:GetshareablelinkSorry,ashareablelinkisnotcurrentlyavailableforthisarticle.Copytoclipboard ProvidedbytheSpringerNatureSharedItcontent-sharinginitiative Accessthroughyourinstitution Changeinstitution Buyorsubscribe Advertisement Explorecontent Researcharticles Reviews&Analysis News&Comment Podcasts Videos Currentissue Collections FollowusonFacebook FollowusonTwitter Subscribe Signupforalerts RSSfeed Aboutthejournal Aims&Scope JournalInformation JournalMetrics AbouttheEditors Ourpublishingmodels EditorialValuesStatement EditorialPolicies ContentTypes WebFeeds Posters Contact Publishwithus SubmissionGuidelines ForReviewers Submitmanuscript Search Searcharticlesbysubject,keywordorauthor Showresultsfrom Alljournals Thisjournal Search Advancedsearch Quicklinks Explorearticlesbysubject Findajob Guidetoauthors Editorialpolicies Closebanner Close SignupfortheNatureBriefingnewsletter—whatmattersinscience,freetoyourinboxdaily. Emailaddress Signup IagreemyinformationwillbeprocessedinaccordancewiththeNatureandSpringerNatureLimitedPrivacyPolicy. Closebanner Close Getthemostimportantsciencestoriesoftheday,freeinyourinbox. SignupforNatureBriefing
延伸文章資訊
- 1Transfer RNA (tRNA)
Transfer RNA (abbreviated tRNA) is a small RNA molecule that plays a key role in protein synthesi...
- 2轉運RNA(transfer RNA, tRNA) - 小小整理網站Smallcollation
轉運RNA(transfer RNA, tRNA) ; Dihydrouridine(D). 將尿嘧啶(U)上的-C=C-雙鍵還原成單鍵而成 ; Pseudouridine(Ψ). 正常尿嘧啶(...
- 3转运核糖核酸- 维基百科,自由的百科全书
转运核糖核酸(Transfer RNA),又称傳送核糖核酸、转移核糖核酸,通常简称為tRNA,是一種由76-90個核苷酸所組成的RNA,其3'端可以在氨酰-tRNA合成酶催化之下,接附 ...
- 4tRNA therapeutics burst onto startup scene - Nature
Companies advance tRNA therapeutics to overcome mutant stoppages in protein synthesis shared by t...
- 5轉運RNA_百度百科
轉運RNA(Transfer RNA),又稱傳送核糖核酸、轉移核糖核酸,通常簡稱為tRNA,是一種由76-90個核苷酸所組成的RNA,其3'端可以在氨酰-tRNA合成酶催化之下,接附特定種類 ...